Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
25 results:

  • 1. External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer.
    Tan F; Bi N; Zhang H; Li R; Wang Z; Duan J; Jiang F; Feng D; Zhang R; Bai J; Cao J; Mao N; Liang K; Yin S; Shen Y; Feng F; Zhao J; Gao Y; Mao Y; Xue Q; Gao S; He J
    Lung Cancer; 2022 Aug; 170():98-104. PubMed ID: 35749952
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Metabolic active tumour volume quantified on [
    Rocha ALG; da Conceição MAM; da Cunha Sequeira Mano FXP; Martins HC; Costa GMLM; Dos Santos Oliveiros Paiva BCB; Lapa PAA
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3601-3611. PubMed ID: 34570257
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/akt signaling pathway.
    Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X
    Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Does the carinal involvement have the same surgical outcome as the main bronchus involvement in patients with non-small cell lung cancer?
    Erdogu V; Citak N; Sezen CB; Aksoy Y; Onay S; Emetli Y; Aker C; Saydam O; Sayar A; Metin M
    Gen Thorac Cardiovasc Surg; 2021 May; 69(5):823-831. PubMed ID: 33185841
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating akt1 as a ceRNA.
    Zhang G; Chen HX; Yang SN; Zhao J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/akt pathway.
    Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
    Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multimodality Therapy for N2 Non-small cell lung cancer: An Evolving Paradigm.
    Spicer JD; Shewale JB; Nelson DB; Mitchell KG; Bott MJ; Vallières E; Wilshire CL; Vaporciyan AA; Swisher SG; Jones DR; Darling GE; Sepesi B
    Ann Thorac Surg; 2019 Jan; 107(1):277-284. PubMed ID: 30227129
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
    Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
    Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of EGFR and KRAS mutations with expression of p-akt, DR5 and DcR1 in non-small cell lung cancer.
    Zhao XD; Deng HB; Lu CL; Bao YX; Lu X; Deng LL
    Neoplasma; 2017; 64(2):182-191. PubMed ID: 28043144
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
    Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
    Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. racial and Ethnic Differences in lung cancer Surgical Stage: An STS Database Study.
    Weksler B; Kosinski AS; Burfeind WR; Silvestry SC; Sullivan J; D'Amico TA
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):538-43. PubMed ID: 25984780
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression and clinical significance of Semaphorin4D in non-small cell lung cancer and its impact on malignant behaviors of A549 lung cancer cells.
    Ruan SS; Li RC; Han Q; Liu J; Li GL; Song YQ; Wu G
    J Huazhong Univ Sci Technolog Med Sci; 2014 Aug; 34(4):491-496. PubMed ID: 25135716
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
    Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E;
    Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Phosphorylated akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis.
    Ke ZF; Mao X; Zeng C; He S; Li S; Wang LT
    Med Oncol; 2013 Mar; 30(1):383. PubMed ID: 23307243
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer.
    Chou PC; Lin SM; Lo CY; Chen HC; Wang CW; Chou CL; Yu CT; Lin HC; Wang CH; Kuo HP
    PLoS One; 2012; 7(10):e47613. PubMed ID: 23056644
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients.
    Vigano A; Del Fabbro E; Bruera E; Borod M
    Crit Rev Oncog; 2012; 17(3):293-303. PubMed ID: 22831160
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
    Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
    Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/akt pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.